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channels with La
3؉ or nifedipine, reduced the amplitude of the Ca 2؉ current triggered by AMPA receptor activation by ϳ65%, but not that initiated by low and high affinity kainate receptors. In contrast, KB-R7943, an inhibitor of the plasma membrane Na 
INTRODUCTION
Oligodendrocytes, the myelinating cells of CNS axons, express functional AMPA and kainate receptors (Verkhratsky and Steinhäuser, 2000) . The physiological significance of these receptors on oligodendrocytes still remains obscure. However, it is well established that prolonged activation of these receptors can lead to oligodendroglial death both in vitro and in vivo (Yoshioka et al., 1996; Matute et al., 1997; Matute, 1998; McDonald et al., 1998) . These findings suggested that traumatic injury, ischemia-related conditions, and demyelinating disorders may cause damage to oligodendrocytes by excitotoxic mechanisms (see for review, Matute et al., 2001) . Indeed, glutamate spillover from affected cells and axons in traumatic lesions of the CNS can kill oligodendrocytes (Li et al., 1999; Rosenberg et al., 1999) . In addition, an AMPA/kainate receptor antagonist reduced ischemia-induced white matter injury in the spinal cord and improved locomotor function (Kanellopoulos et al., 2000) . Moreover, this antagonist ameliorated the neurological deficits of rats in which experimental autoimmune encephalomyelitis had been previously induced (Pitt et al., 2000) . Therefore, understanding the mechanisms which trigger oligodendroglial death upon AMPA and kainate receptor activation, may contribute to the development of therapeutical agents with the potential to alleviate neurological conditions involving oligodendrocyte loss.
Glutamate receptor-mediated excitotoxicity in oligodendrocytes, as well as in neurons, is initiated by an excessive influx of Na ϩ and Ca 2ϩ through the activated receptor (McDonald et al., 1998; Sánchez-Gó mez and Matute, 1999 
